Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares Issued Shares Outstanding Shares Outstanding

Ratios

Rein Therapeutics (RNTX) Shares Issued (2016 - 2025)

Rein Therapeutics filings provide 8 years of Shares Issued readings, the most recent being $3000.0 for Q4 2025.

For the quarter ending Q4 2025, Shares Issued fell 99.96% year-over-year to $3000.0, compared with a TTM value of $4000.0 through Dec 2025, down 99.94%, and an annual FY2025 reading of $4000.0, down 99.94% over the prior year.
Shares Issued hit $3000.0 in Q4 2025 for Rein Therapeutics, up from -$366000.0 in the prior quarter.
The five-year high for Shares Issued was $55.6 million in Q1 2021, with the low at -$55.5 million in Q4 2021.
Median Shares Issued over the past 3 years was -$9000.0 (2021), compared with a mean of $710800.0.
The largest YoY upside for Shares Issued was 9973.19% in 2021 against a maximum downside of 1072.65% in 2021.
Year by year, Shares Issued stood at -$55.5 million in 2021, then soared by 112.66% to $7.0 million in 2024, then plummeted by 99.96% to $3000.0 in 2025.
According to Business Quant data, Shares Issued over the past three periods came in at $3000.0, -$366000.0, and -$345000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.